|
AMMECR1L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64868119156836E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.76558808976324E-12 |
| Normal-vs-Stage2 |
8.68020000321934E-09 |
| Normal-vs-Stage3 |
5.23779908334632E-11 |
| Normal-vs-Stage4 |
1.20840004669276E-11 |
| Stage1-vs-Stage2 |
3.705200E-01 |
| Stage1-vs-Stage3 |
1.605600E-01 |
| Stage1-vs-Stage4 |
4.178300E-02 |
| Stage2-vs-Stage3 |
8.847600E-01 |
| Stage2-vs-Stage4 |
3.723600E-01 |
| Stage3-vs-Stage4 |
4.211200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.64264174379514E-13 |
| Normal-vs-AfricanAmerican |
2.227800E-04 |
| Normal-vs-Asian |
3.48869999999835E-07 |
| Caucasian-vs-AfricanAmerican |
4.190600E-01 |
| Caucasian-vs-Asian |
5.323600E-01 |
| AfricanAmerican-vs-Asian |
7.631000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.75079950537338E-11 |
| Normal-vs-Female |
1.76580972066631E-12 |
| Male-vs-Female |
5.303200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.59909998973274E-10 |
| Normal-vs-Age(41-60Yrs) |
1.00963681859412E-12 |
| Normal-vs-Age(61-80Yrs) |
2.03070893434187E-12 |
| Normal-vs-Age(81-100Yrs) |
6.575200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.094560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.848100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.659000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.992600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.868000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.973800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.308400E-02 |
| Classical-VS-Follicular |
5.007400E-04 |
| Classical-VS-Other |
3.299200E-01 |
| Classical-VS-Normal |
1.6028001148527E-10 |
| Tall-VS-Follicular |
8.227200E-01 |
| Tall-VS-Other |
9.494800E-01 |
| Tall-VS-Normal |
2.75289999684958E-08 |
| Follicular-VS-Other |
8.542600E-01 |
| Follicular-VS-Normal |
2.34945396471176E-12 |
| Other-VS-Normal |
1.783260E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.53130849614536E-14 |
| Normal-vs-N1 |
4.61039995069967E-09 |
| N0-vs-N1 |
9.821400E-01 |
|
|
